VEGFA and Hypertension: In an institutional review board-approved case series Patel et al. described seven patients who developed a “preeclampsia-like syndrome” characterized by hypertension and proteinuria after starting therapy with sunitinib and sorafenib, two multityrosine kinase inhibitors interfering with VEGF signalling.